MICHAELA SKELLY: Open Payments
NPI 1427097021 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,278 in 120 payments from 29 companies in 2025. Trend: 2023 $2,557 · 2024 $3,759 · 2025 $3,278
Food & beverage: $3,278
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $636 |
| AstraZeneca Pharmaceuticals LP | 8 | $359 |
| Inspire Medical Systems, Inc. | 1 | $348 |
| Amgen Inc. | 15 | $199 |
| Astellas Pharma US Inc | 7 | $190 |
| ABBVIE INC. | 10 | $189 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $175 |
| PFIZER INC. | 9 | $170 |
| Radius Health, Inc. | 7 | $148 |
| Edwards Lifesciences Corporation | 1 | $143 |
Products named: INSPIRE, Wegovy, Ozempic, Veozah, BREZTRI, Kerendia, FARXIGA, Tymlos.
Industry payments across AZ — which companies pay providers there.
